Literature DB >> 12925227

Heme-scavenging role of alpha1-microglobulin in chronic ulcers.

Maria Allhorn1, Katarina Lundqvist, Artur Schmidtchen, Bo Akerström.   

Abstract

Chronic venous ulcers are characterized by chronic inflammation. Heme and iron, originating from blood cell hemolysis as well as extravascular necrosis, have been implicated as important pathogenic factors due to their promotion of oxidative stress. It was recently reported that the plasma and tissue protein alpha1-microglobulin is involved in heme metabolism. The protein binds heme, and a carboxy-terminally processed form, truncated alpha1-microglobulin, also degrades heme. Here, we show the presence of micromolar levels of heme and free iron in chronic leg ulcer fluids. Micromolar amounts of alpha1-microglobulin was also present in the ulcer fluids and bound to added radiolabeled heme. Truncated alpha1-microglobulin was found in the ulcer fluids and exogenously added alpha1-microglobulin was processed into the truncated alpha1-microglobulin form. Histochemical analysis of chronic wound tissue showed the presence of iron deposits, heme/porphyrins in infiltrating cells basement membranes and fibrin cuffs around vessels, and alpha1-microglobulin ubiquitously distributed but especially abundant in basement membranes around vessels and at fibrin cuffs. Our results suggest that alpha1-microglobulin constitutes a previously unknown defense mechanism against high heme and iron levels during skin wound healing. Excessive heme and iron, which are not buffered by alpha1-microglobulin, may underlie the chronic inflammation in chronic ulcers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925227     DOI: 10.1046/j.1523-1747.2003.12409.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

Review 1.  An overview of the relationship between anaemia, iron, and venous leg ulcers.

Authors:  Amy E Ferris; Keith G Harding
Journal:  Int Wound J       Date:  2019-08-16       Impact factor: 3.315

2.  Alpha1-microglobulin as an early biomarker of sepsis-associated acute kidney injury: a prospective cohort study.

Authors:  I Terzi; V Papaioannou; N Papanas; C Dragoumanis; A Petala; V Theodorou; T Gioka; V Vargemezis; E Maltezos; I Pneumatikos
Journal:  Hippokratia       Date:  2014 Jul-Sep       Impact factor: 0.471

3.  Up-regulation of A1M/α1-microglobulin in skin by heme and reactive oxygen species gives protection from oxidative damage.

Authors:  Magnus G Olsson; Maria Allhorn; Jörgen Larsson; Martin Cederlund; Katarina Lundqvist; Artur Schmidtchen; Ole E Sørensen; Matthias Mörgelin; Bo Akerström
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

4.  Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1.

Authors:  Pavel Májek; Zuzana Reicheltová; Jiří Suttnar; Martin Malý; Milan Oravec; Klára Pečánková; Jan E Dyr
Journal:  J Transl Med       Date:  2011-06-01       Impact factor: 5.531

5.  Proteomic identification of novel differentiation plasma protein markers in hypobaric hypoxia-induced rat model.

Authors:  Yasmin Ahmad; Narendra K Sharma; Mohammad Faiz Ahmad; Manish Sharma; Iti Garg; Kalpana Bhargava
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

6.  A1M/α1-microglobulin is proteolytically activated by myeloperoxidase, binds its heme group and inhibits low density lipoprotein oxidation.

Authors:  Martin Cederlund; Adnan Deronic; Jan Pallon; Ole E Sørensen; Bo Åkerström
Journal:  Front Physiol       Date:  2015-02-03       Impact factor: 4.566

7.  The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.

Authors:  Magnus Gram; Ulrik Dolberg Anderson; Maria E Johansson; Anneli Edström-Hägerwall; Irene Larsson; Maya Jälmby; Stefan R Hansson; Bo Åkerström
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.